Il Xxxvii Convegno Della Società Degli Urologi Del Nord Italia: Tavola Rotonda. I. Chemioterapia Neo-Adiuvante Del Carcinoma Della Vescica

Soloway M.S. : Selecting initial therapy for bladder cancer. Cancer, 60; 502 (1987).

Pavone Macaluso M. , Tripi M. , Pavone C. , Ingargiola G.B. : Chemotherapy of bladder cancer. In: Bladder cancer, N. Javadpour, p. 190–202. Williams & Wilkins, Baltimore & London 1984.

Gabrilove J.L. , Welz K. , Harris P. : Pluripoietin alfa; a second human hematopoietic colony-stimulating factor, produced by the human bladder carcinoma cell line 5637. Proc. Natl. Acad. Sci. USA, 83; 2478 (1986).

Messing E.M. , Bubbers J.E. , Dekernion J.B. , Fahey J.L. : Growth stimulating activity produced by human bladder cancer. J. Urol., 132; 1230 (1984).

Gallo R. , Ruscetti F.H. : New human hematopoietic cell system for the study of growth, differentiation and involved factors; some therpeutic implications. In: Molecular actions and targets for cancer chemotherapeutic agents, p. 561–577. Academic Press, New York London 1981.

Neal D.E. , Marsh C. : Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet, 1/8425; 366 (1985).

Barrios L. , Miro R. , Caballin M.R. : Constitutional (3) (p. 14 - p. 21) in a patient with bladder carcinoma. Cancer Genet. Cytogenet., 21; 171 (1986).

Russo G.R. , Reggiani A. , Romano A. , Maestri I. , Del Senno L. : Studio degli oncogèni Ha-RAS, ROS, MYC e loro rapporto con il grading istologico nelle neo-plasie vescicali. Acta Urol. Ital., 1; 397 (1987).

Prodi G. : La biologia dei tumori, p. 74. Am-brosiana, Milano 1977.

Adams G.G. , Stratford I.J. : Hypoxia-dependent radiation sensitizers and chemotherapeutic agents. In: Molecular actions and targets for cancer chemotherapeutic agents, p. 401–418. Academic Press, New York London 1981.

Wells M. , Anderson K. : Mucin biochemistry of cystitis glandularis and primary adenocarcinoma of the urinary bladder. Arch. Pathol. Lab. Med., 109; 59 (1985):

Wurzel R.S. , Yamase H.T. , Nieh P.T. : Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract. J. Urol., 137; 502 (1986).

Satke T. , Takeda A. , Matsuyama M. : Argyrophil cells in the urachal epithelium and urachal adenocarcinoma. Acta Pathol. JPN., 34; 1193 (1984).

Oliver R.T.D. , Waxman J. , Stephenson C. , Riddle P. , O'Donoghue E.P.N. , Hendry W.F. , Blandy J.P. : Current status of chemotherapy for metastatic and recurrent primary urothelial malignancy. In: Intern. Workshop in Urology, Cannes 1987. Acta Urol. Ital., suppl. 1 (1987).

Bertino J.R. , Dolnick B.J. , Berenson R.J. , Scheer D.I. , Kamen B.A. : Cellular mechanisms of resistance to metotrexate. In: Molecular actions and targets for cancer therapeutic agents, p. 385–397. Academic Press, New York & London 1981.

Wolf H. , Rosenchilde Olsen P. , Fisher A. , Hojgard K. : Urothelial atypia concomitant with primary bladder tumour. Incidence in a consecutive series of 500 unselected patients. Scand. J. Urol. Nephrol., 21, 33 (1987).

Maier U. , Holzner J.H. : Stellenwert der Urotheldysplasien in makroskopisch normaler Schleimhaut bei Patienten mit Blasentumoren. Ergebnis einer randomisierten Studie mit und ohne intra-vesikaler Mitomycin C Rezidivprophylaxe. Onkologie, 8; 232 (1985).

Smith A.F. : An ultrastructural and morphometric study of bladder tumours. Wirchows Arch. Abt. A. Pathol. Anat., 406; 7 (1985).

Heiander K. , Hofer P.A. , Holmberg G. : Karyometric investigations on urinary bladder carcinoma, correlated to histopathological grading. Wirchows Arch. Abt. A. Pathol. Anat., 403; 117 (1984).

De Sanctis P.N. , Conception N.B. , Tannenbaum M. , Olsson C. : Quantitative morphometry measurements of transitional cell bladder cancer as indicator of tumor aggression. Urology, 29; 322 (1987).

Turini D. : Atti S.I.U., 1986.

Fossa S.D. , Reitan J.B. , Ous S. : Prediction of tumor progression in superficial bladder carcinoma. Eur. Urol., 11, 1 (1985).

Mori K. , Toshaki S. , Yamagiwa K. , Ohkawa T. : Mechanism of the LAI test in bladder cancer patients J. Urol., 135; 856 (1986).

Czerniak B. , Koss L.G. , Sherman A. : Nuclear pores and DNA ploidy in human bladder carcinoma. Cancer Res., 44, 3752 (1984).

Maul G.G. , Deaven L.L. , Freed J.J. , Campbell G. , Le M. , Becak W. : Investigation of the determinants of nuclear pore number. Cytogenet. Cell. Genet., 26; 175 (1980).

Tribukait B. , Gustafson H. , Esposti P.L. : Ploidy and proliferation of human bladder tumors as measured by flow cytometry DNA-analysis and its relation to histopathology and cytology. Cancer, 143; 1742 (1979).

Nemoto R. , Uchida K. , Hattori K. , Shimazui T. , Nishijima Y. , Saito S. , Koiso K. , Harada M. : S-phase fraction of human bladder tumor measured in situ with bromodeoxyu-ridine labeling. J. Urol., 139; 286 (1988).

Caramo Fonseca M. , David-Ferreira J.F. : Quantitative study of nuclear pore complexes in ventral prostate isolated nuclei from intact and castrated rats. J. Ultrastruct. Res., 76; 202 (1981).

Many M.C. , Denet J.F. , Cordier A.C. , Haumont S. : Morphometry of nuclear pore complexes in thyroid cells during hyperplasia and involution. Mol. Cell. Endocrinol., 23; 137 (1981).

Walts A.E. , Said J.W. , Siegel M.B. , Banks-Schlegel S. : Involucrin, a marker of squamous and urothelial differentiation. An immunohistochemical study on its distribution in normal and neoplastic tissues. J. Pathol., 145; 329 (1985).

Hashimoto H. , Sakashita S. : Laminin: a basement membrane specific glycoprotein in bladder carcinoma. Urol. Intern., 41; 248 (1986).

Gelli M.C. , Alampi G. , Malatesta G. , Zaganelli S. , Galassi A. , Piccaluga G. , Soli M. , Manferrari F. , Biscardi A. , Fraci F. : Studio della membrana basale nei carcinomi della vescica: il comportamento della lamina e del collageno. Acta Urol. Ital., 1; 409 (1987).

Nemoto S. , Koiso K. , Aoyagi K. , Tojo S. : Ekstase. Does this enzyme play a role in bladder cancer invasion? J. Urol., 134; 996 (1985).

De Klerk D.P. : The glycosaminoglycans of human bladder cancers of varying grade and stage. J. Urol., 134; 978 (1985).

Steffens J. , Friedmann W. , Lobeck H. : Immunohistochemical demonstration of tumor-associated antigen with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder. Urol. Res., 13; 55, (1985).

Ohoka H. , Shinomiya H. , Jokoyama M. , Ochi K. , Takeuchi M. , Utsumi’ S. : Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence. Urol. Res., 13; 47 (1985).

Yamada T. , Fukui I. , Yokokawa M. , Oshima H. : Changing expression of ABH blood group and cryptic T-antigens of non-invasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression. Cancer, 61; 721 (1988).

Borgström E. , Wahren B. , Gustafson H. : Fluorescence methods for measuring the A, B and H insoantigens on cytological material from bladder carcinoma. Urol. Res., 13; 43 (1985).

Sadoughi N. , Rubestone A. , Mlsna J. , Davidsohn I. : The cell surface antigens of bladder washing specimes in patients with bladder tumors: a new approach. J. Urol., 123; 119 (1980).

Sadoughi N. , Mlsna J. , Guinan P. , Rubenstone A. : Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma. Urology, 20; 143 (1982).

Stephenson T.I. : Monoclonal antibodies to detect A, B and blood group isoantigens (BGI) in superficial transitional cell carcinoma of the bladder. A means of predicting invasive recurrences. Brit. J. Urol., 57; 148 (1985).

Czerniak B. , Koss L.G. : Expression of ca-antigen on human bladder tumors. Cancer, 55; 2380 (1985).

Rockwood A.P. , Mori K. , Lamm D.Z. : Serum lymphocyte adherence inhibition test in bladder cancer patients. J. Urol., 136; 1009 (1986).

Adolph H.D. , Oehr P. : Significance of plasma polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer. Urol. Res., 12; 125 (1984).

Cicogoi A. , Rocca Rossetti S. : Valori ematici e urinari di CEA e Cai_19-9 in pazienti affetti da carcinoma vescicale. Minerva med., 77; 1983 (1986).

Kobayashi K. , Umeda T. , Akaza H. : Circulating immunocomplexes in patients with bladder cancer and other malignancies of the urogenital tract. Urol. Intern., 39; 232 (1984).

Skaarup P. , Jen-senius J.C. , Brandslund I. , Svehag S.E. Wolf H. : Association of circulating immune complexes with glomerular proteinuria in patients with transitional cell carcinoma of the bladder. Eur. Urol., 10; 249 (1984).

Koshida K. , Harmenberg J. , Stendahl U. , Warhen B. , Borgström E. , Helström L. , Anderson L. : Urinary modified nucleosides as tumor markers in cancer of the urinary organs and female genital tract. Urol. Res., 13; 213 (1985).

Iakse G. , Loidl W. , Seeberg G. : Das T1G3 - Urothelkarzinon der Harnblase. Aktuelle Urol., 16; 304 (1985).

Adolph H.D. , Schwabe H.W. , Helpap B. , Volz C. : Cytomorphological studies on the urothelium during and after chemoimmune prophylaxis. Urol. Res., 12; 129 (1984).

Helpap B. , Vogel J. , Oehr P. , Adolphs H.D. : Comparison between cell kinetical and immunohistochemical studies on carcinoma and atypia (dysplasia) of urinary bladder mucosa. Wirchows Arch. Abt. A. Pathol. Anat. Histopathol., 406; 309 (1985).

Steel G.G. : Growth kinetics of tumors. Oxford Univ. Press, London New York 1977.

Kallman R.F. , Rockwell S. : Cancer: a comprehensive treatise. Vol. 6, 255. Plenum Press, New York 1977.

Kennedy K.A. , Teicher B.A. , Rockwell S. , Sartorelli A.C. : Chemotherapeutic approach to cell populations of tumors. In: Molecular actions and targets for cancer chemotherapeutic agents, 85–101. Academic Press, New York London 1981.

Whelan P. , Flynn C. , Ramsden C. : Choosing the right intravesical therapeutic agent. Results of an in vitro monolayer cell culture assay. Brit. J. Urol., 56; 655 (1984).

Walter P.J. , Paulson D.F. : Laboratory chemosensitivity testing of human bladder carcinoma. World J. Urol., 3; 104 (1985).

Anderson K.C. , Simpson W.G. , Ballou R.J. : In vitro sensitivity of J-82 human bladder cancer cells. Urol. Res., 14; 141 (1986).

Hepburn P.J. , Oliver R.T.D. , Riley P.A. , Hill B.T. , Masters J.R.W. : Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line. Urol. Res., 13; 27 (1985).